The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy.

Young, Caroline A; Murray, Louise J; Karakaya, Ebru; Thygesen, Helene H; Sen, Mehmet; Prestwich, Robin J D

Young, Caroline A; Murray, Louise J; Karakaya, Ebru; Thygesen, Helene H; Sen, Mehmet; Prestwich, Robin J D.

Afiliación

Young CA; Department of Clinical Oncology, St. James's Institute of Oncology, Leeds, UK.
Murray LJ; Department of Clinical Oncology, St. James's Institute of Oncology, Leeds, UK.
Karakaya E; Department of Clinical Oncology, St. James's Institute of Oncology, Leeds, UK.
Thygesen HH; Leeds Institute of Cancer and Pathology, Leeds, UK.
Sen M; Department of Clinical Oncology, St. James's Institute of Oncology, Leeds, UK.
Prestwich RJ; Department of Clinical Oncology, St. James's Institute of Oncology, Leeds, UK.

Clin Med Insights Oncol ; 8: 81-6, 2014.

Article en En | MEDLINE | ID: mdl-25057245

Palabras clave

chemotherapy; neutrophil-to-lymphocyte ratio; oropharynx cancer; radiotherapy; squamous cell cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Med Insights Oncol Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google